Secondary amenorrhoea
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
First-line tests (pregnancy excluded)
Fasting laboratory tests between 7 am and 11 am
- FSH
- LH
- TSH
- Free T4 (if FSH, LH and oestradiol low or pituitary involvement suspected)if needednon-French guidelineTSH is the first-line thyroid test for any menstrual disorder, but it is hard to interpret in hypothyroidism of pituitary origin (for example Sheehan's syndrome): ASRM (2024) then asks to add free T4 [1]. First-line, ASRM retains TSH alone, free T4 being added if TSH is abnormal or in case of pituitary involvement [1].
- Prolactin
- Oestradiol
- Serum testosterone (if signs of hyperandrogenism or PCOS suspected)if needednon-French guidelineTo request when amenorrhoea comes with signs of hyperandrogenism (hirsutism, acne, alopecia) or when the picture suggests PCOS: total testosterone helps to document hyperandrogenism and look for its origin [1,2].
- SHBG (if signs of hyperandrogenism or PCOS suspected, with testosterone)if needednon-French guidelineTo combine with testosterone when looking for biochemical hyperandrogenism: the international PCOS guideline (2023, endorsed in Australia by the NHMRC) assesses it by total and free testosterone, free testosterone being estimable by the free androgen index, calculated from SHBG [2]; a Scottish primary care pathway (NHS Borders, 2025) asks for SHBG and free androgen index straight away [3]. The French Society of Endocrinology (2010) recommends total testosterone first-line and cites SHBG only to interpret a discordant result (low in overweight or metabolic syndrome, high on oestrogen-like treatment, in hyperthyroidism or liver disease) [4].
- hCGif needednon-French guidelineAs long as pregnancy has not been formally excluded: it is the first diagnosis to exclude before hormone tests. A urine test can be falsely negative; a blood test may be preferred [1].
Also consider
- Raised prolactin? If prolactin is raised, see the Hyperprolactinaemia page.
Do not order
Tests if serum testosterone is raised
Laboratory tests
- Synacthen test with 17-hydroxyprogesterone
24-hour urine collection
- Urinary free cortisol
- DHEA-S (if testosterone > 2 times normal)if neededTotal testosterone above twice the upper limit: DHEA-S points to an adrenal origin (very high level) or ovarian origin (normal level) [4]. NABM coverage limited to adrenal diseases (code 1802): justified here if an adrenal tumour or hyperplasia is suspected [6].
Also consider
Raised FSH (> 25 IU/L): premature ovarian insufficiency
Laboratory tests
- FSH (repeat at 4-6 weeks)if needednon-French guidelineDiagnostic doubt (initial value poorly consistent with the clinical picture): ESHRE asks to repeat FSH after 4 to 6 weeks; a single measurement is enough if the picture is typical [5].
- Blood karyotype (attach the information and consent certificate)
- FMR1 premutation testing (fragile X)if needednon-French guidelineRecommended by ESHRE in every woman with non-iatrogenic ovarian insufficiency, after information on the implications of the test [5]; see the page "Genetic tests: prescribing framework".
- Anti-21-hydroxylase antibodiesif neededOvarian insufficiency of unknown cause: ESHRE recommends looking for them (if positive: endocrinology opinion to investigate adrenal function) [5]. Only code 1489 (anti-adrenal antibodies by immunofluorescence) exists in the NABM: check with the laboratory [6].
Sources (8)
- Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion. Fertil Steril. 2024;122(1):52-61.
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023.
- NHS Borders. Borders RefHelp Toolkit : Amenorrhoea. Right Decision Service (Écosse), dernière relecture le 24/07/2025.
- Pugeat M, Déchaud H, Raverot V, et al.; Société française d'endocrinologie. Recommendations for investigation of hyperandrogenism. Ann Endocrinol (Paris). 2010;71(1):2-7.
- ESHRE Guideline Group on POI ; Panay N, Anderson RA, Bennie A, et al. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open. 2024;2024:hoae065.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 0901 (caryotype), 1489 (anticorps antisurrénale), 1802 (SDHEA), 4050 (FMR1).
- Peña AS, Witchel SF, Hoeger KM, et al. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18:72.
- National Institute for Health and Care Excellence. Menopause: identification and management. NICE guideline NG23, publiée le 12 novembre 2015, mise à jour le 15 avril 2026.